We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICER Panel Reviews the Aduhelm Roller Coaster: Says it’s Not Worth the Ticket Price
ICER Panel Reviews the Aduhelm Roller Coaster: Says it’s Not Worth the Ticket Price
How do you determine a drug’s cost/benefit ratio when you know the cost to procure and administer it could soar to $100,000 each year, but the benefit could be zero?